Literature DB >> 21512791

Sporadic isolations of a multi-drug resistant Pseudomonas aeruginosa clone during a 14-month epidemic in a general hospital in Hiroshima.

S Kouda1, Y Fujiue, Y Watanabe, M Ohara, S Kayama, F Kato, J Hisatsune, K Tsuruda, A Matsubara, M Doi, M Kuwabara, M Sugai.   

Abstract

BACKGROUND: During 2005-2007, we experienced sporadic isolations of multidrug-resistant (MDRP) Pseudomonas aeruginosa from wards in a general hospital in Hiroshima. The objective of this study was to analyze epidemiology relationships and the mode of spread of the strains.
METHODS: Clonality was assessed using pulsed-field gel electrophoresis (PFGE) and serotyping. MICs were determined using the microdilution broth method. Investigations of the affected patients' movements and environmental sampling from the affected wards were conducted.
RESULTS: An abrupt increase in MDRP isolations began at the end of 2005 and ended in February 2007. A total of 25 MDRP strains were sporadically isolated from nine wards. Fourteen strains were genotypically and serologically identical. Analysis of the patients' movements identified that six of the 14 MDRP-positive patients became positive for MDRP when they were in the intensive care unit (ICU), and two became positive after the patients moved from the ICU to another nursing unit. Four MDRP strains were isolated from patients who did not stay in the ICU and were in ward E6, which had the second highest number of isolations. In July 2006, environmental sampling of the hospital identified a toilet brush in ward E6 that was contaminated with MDRP that was genotypically and serologically identical to the clinical isolates.
CONCLUSIONS: Our study suggests that the sporadic increase in MDRP isolates during 2005-2007 in the general hospital in Hiroshima was due to an epidemic of an MDRP clone. Continuity and spread of infection was probably due to cross infection and contamination in the hospital with the MDRP strain.

Entities:  

Mesh:

Year:  2011        PMID: 21512791     DOI: 10.1007/s15010-011-0111-y

Source DB:  PubMed          Journal:  Infection        ISSN: 0300-8126            Impact factor:   3.553


  22 in total

Review 1.  Nosocomial infections due to multidrug-resistant Pseudomonas aeruginosa: epidemiology and treatment options.

Authors:  Marilee D Obritsch; Douglas N Fish; Robert MacLaren; Rose Jung
Journal:  Pharmacotherapy       Date:  2005-10       Impact factor: 4.705

2.  Device-associated nosocomial infections in 55 intensive care units of 8 developing countries.

Authors:  Victor D Rosenthal; Dennis G Maki; Reinaldo Salomao; Carlos Alvarez Moreno; Yatin Mehta; Francisco Higuera; Luis E Cuellar; Ozay Akan Arikan; Rédouane Abouqal; Hakan Leblebicioglu
Journal:  Ann Intern Med       Date:  2006-10-17       Impact factor: 25.391

Review 3.  Interpreting chromosomal DNA restriction patterns produced by pulsed-field gel electrophoresis: criteria for bacterial strain typing.

Authors:  F C Tenover; R D Arbeit; R V Goering; P A Mickelsen; B E Murray; D H Persing; B Swaminathan
Journal:  J Clin Microbiol       Date:  1995-09       Impact factor: 5.948

Review 4.  Polysaccharide antigens of Pseudomonas aeruginosa.

Authors:  Y A Knirel
Journal:  Crit Rev Microbiol       Date:  1990       Impact factor: 7.624

Review 5.  Ecology of Pseudomonas aeruginosa in the intensive care unit and the evolving role of water outlets as a reservoir of the organism.

Authors:  Matthias Trautmann; Philipp M Lepper; Mathias Haller
Journal:  Am J Infect Control       Date:  2005-06       Impact factor: 2.918

6.  Environmental contamination with an epidemic strain of Pseudomonas aeruginosa in a Liverpool cystic fibrosis centre, and study of its survival on dry surfaces.

Authors:  S Panagea; C Winstanley; M J Walshaw; M J Ledson; C A Hart
Journal:  J Hosp Infect       Date:  2005-02       Impact factor: 3.926

7.  Identification of airborne dissemination of epidemic multiresistant strains of Pseudomonas aeruginosa at a CF centre during a cross infection outbreak.

Authors:  A M Jones; J R W Govan; C J Doherty; M E Dodd; B J Isalska; T N Stanbridge; A K Webb
Journal:  Thorax       Date:  2003-06       Impact factor: 9.139

8.  Increased prevalence and clonal dissemination of multidrug-resistant Pseudomonas aeruginosa with the blaIMP-1 gene cassette in Hiroshima.

Authors:  Syuntaro Kouda; Masaru Ohara; Makoto Onodera; Yoshihiro Fujiue; Megumi Sasaki; Tadahiro Kohara; Seiya Kashiyama; Shizue Hayashida; Toshie Harino; Takahiro Tsuji; Hideyuki Itaha; Naomasa Gotoh; Akio Matsubara; Tsuguru Usui; Motoyuki Sugai
Journal:  J Antimicrob Chemother       Date:  2009-04-27       Impact factor: 5.790

9.  Ventilator-associated pneumonia: caveats for benchmarking.

Authors:  Philippe Eggimann; Stéphane Hugonnet; Hugo Sax; Sylvie Touveneau; Jean-Claude Chevrolet; Didier Pittet
Journal:  Intensive Care Med       Date:  2003-09-03       Impact factor: 17.440

10.  The prevalence of nosocomial infection in intensive care units in Europe. Results of the European Prevalence of Infection in Intensive Care (EPIC) Study. EPIC International Advisory Committee.

Authors:  J L Vincent; D J Bihari; P M Suter; H A Bruining; J White; M H Nicolas-Chanoin; M Wolff; R C Spencer; M Hemmer
Journal:  JAMA       Date:  1995 Aug 23-30       Impact factor: 56.272

View more
  2 in total

Review 1.  A systematic review and meta-analyses show that carbapenem use and medical devices are the leading risk factors for carbapenem-resistant Pseudomonas aeruginosa.

Authors:  Anne F Voor In 't Holt; Juliëtte A Severin; Emmanuel M E H Lesaffre; Margreet C Vos
Journal:  Antimicrob Agents Chemother       Date:  2014-02-18       Impact factor: 5.191

2.  The Concerted Action of Two B3-Like Prophage Genes Excludes Superinfecting Bacteriophages by Blocking DNA Entry into Pseudomonas aeruginosa.

Authors:  Marco Antonio Carballo-Ontiveros; Adrián Cazares; Pablo Vinuesa; Luis Kameyama; Gabriel Guarneros
Journal:  J Virol       Date:  2020-07-16       Impact factor: 5.103

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.